no but most clinical trials don’t meet starting aims. To be saying boom based on a trial is ambitious. no a company needs to keep its focus on its primary business. This side game will cost money. Where is it coming from? That money and Human Resources takes away from primary objectives like Malta. dont have a crystal ball just playing the odds. When all the worlds scientists are focussing on this problem why would mxc be likely to succeed when others fail. added to that mxc track record of delivering on anything is not great
MXC Price at posting:
3.5¢ Sentiment: Sell Disclosure: Held
